Kristin Yarema
Chief Executive Officer at ImageneBio Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: ImageneBio Inc., 1 year.
Chief executive roles
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-77.1% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | ImageneBio Inc. | Grant or award | +254,800 | — | — |
| Jul 25, 2026 | ImageneBio Inc. | Option exercise | +38,376 | — | — |
| Jul 25, 2026 | ImageneBio Inc. | Other | +115,129 | — | — |
| Mar 16, 2026 | ImageneBio Inc. | Grant or award | +85,400 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.